Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients

Bridget Draper; Win Lei Yee; Alisa Pedrana; Khin Pyone Kyi; Huma Qureshi; Hla Htay; Win Naing; Alexander J Thompson; Margaret Hellard; Jessica Howell

doi:10.1016/j.lanwpc.2021.100359

Reducing liver disease-related deaths in the Asia-Pacific: the important role of decentralised and non-specialist led hepatitis C treatment for cirrhotic patients

Lancet Reg Health West Pac. 2022 Jan 1:20:100359. doi: 10.1016/j.lanwpc.2021.100359. eCollection 2022 Mar.

Authors

Bridget Draper^{1

2}, Win Lei Yee³, Alisa Pedrana^{1

2

4}, Khin Pyone Kyi⁵, Huma Qureshi⁶, Hla Htay³, Win Naing^{5

7}, Alexander J Thompson^{8

9}, Margaret Hellard^{1

2

10

11

12}, Jessica Howell^{1

2

8

9}

Affiliations

¹ Disease Elimination Program, Burnet Institute Melbourne, Australia.
² School of Public Health and Preventive Medicine, Monash University Melbourne, Australia.
³ Burnet Institute Yangon, Myanmar.
⁴ Health Services Research and Implementation, Monash Partners, Melbourne, Australia.
⁵ Myanmar Liver Foundation.
⁶ Gastroenterologist, Doctors Plaza, Clifton, Karachi, Pakistan.
⁷ Yangon Specialty Hospital, Myanmar.
⁸ St Vincent's Hospital Melbourne, Australia.
⁹ Department of Medicine, University of Melbourne, Australia.
¹⁰ Hepatitis Services, Department of Infectious Diseases Alfred Hospital Melbourne Australia.
¹¹ Doherty Institute, Melbourne, Australia.
¹² School of Population and Global Health, University of Melbourne, Australia.

No abstract available

Publication types

Review